Induction of CD8+ CTL recognizing mycobacterial peptides

Scandinavian Journal of Immunology

Volumn 45, Issue 5, 1997, Pages 521-526

  Vordermeier, H M ^a   Zhu, X ^a   Harris, D P ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; H2 SYSTEM; IMMUNIZATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0030914581     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-432.x     Document Type: Article

References (43)

1. + T cell lines. Eur J Immunol 1988;18:59-66.
2. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992;89:12013-17.
3. + T cells. Infect Immun 1987;55:2037-41.
4. Kaleab B, Ottenoff T, Converse P et al. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Eur J Immunol 1990; 20:2651-9.
5. Rees A, Scoging A, Mehlert A, Young DB, Ivanyi J. Specificity of proliferative response of human CD8 clones to mycobacterial antigens. Eur J Immunol 1988;18:1881-7.
6. Ottenhoff THM, Mutis T. Role of cytotoxic cells in the protective immunity against and immunopathology of intracellular infections. Eur J Clin Invest 1995;25:371-7.
7. + cells in tuberculosis. Lancet 1992;339:315-16.
8. Van Den Oord JJ, De Wolf-Peeters C, Facchetti F, De Smet VJ. Cellular composition of hypersensitivity-type granulomas: immuno-histochemical analysis of tuberculous and sarcoidal lymphadenitis. Human Pathology 1984;15:559-65.
9. Rhandhawa PS. Lymphocyte subsets in granulomas of human tuberculosis: an in situ immunofluorescence study using monoclonal antibodies. Pathology 1990;22:153-5.
10. Minden P, Houghten RA, Spear JR, Shinnick TM. A chemically synthesized peptide which elicits humoral and cellular immune responses to mycobacterial antigens. Infect Immun 1986;53:560-4.
11. Verbon A, Hartskeerl RA, Schuitema A, Kolk AH, Young DB, Lathigra R. The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins. J Bacteriol 1992;174:1352-9.
12. Ashbridge KR, Booth RJ, Watson JD, Lathigra RB. Nucleotide sequence of the 19kDa antigen gene from Mycobacterium tuberculosis. Nucleic Acids Res 1989;17:1249.
13. Andersen AB, Hansen EB. Structure and mapping of antigenic domains of protein antigen b, a 38,000-molecular-weight protein of Mycobacterium tuberculosis. Infect Immun 1989;57:2481-8.
14. Thole JE, Keulen WJ, De BJ et al. Characterization, sequence determination, and immunogenicity of a 64-kilodalton protein of Mycobacterium bovis BCG expressed in Escherichia coli K-12. Infect Immun 1987;55:1466-75.
15. Garsia RJ, Hellqvist L, Booth RJ et al. Homology of the 70-kilodalton antigens from Mycobacterium leprae and Mycobacterium bovis with the Mycobacterium tuberculosis 71-kilodalton antigen and with the conserved heat shock protein 70 of eucaryotes. Infect Immun 1989;57:204-12.
16. Rammensee HG, Friede T, Stevanoviic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995;41:178-228.
17. Townsend A, Ohlen C, Bastin J, Ljunggren HG, Foster L, Karre K. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989;340:443-8.
18. Harris DP, Vordermeier HM, Friscia G, et al. Genetically permissive recognition of adjacent epitopes from the 19-kDa antigen of Mycobacterium tuberculosis by human and murine T cells. J Immunol 1993;150:5041-50.
19. Stauss HJ, Davies H, Sadovnikova E, Chain B, Horowitz N, Sinclair C. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in human papilloma virus. Proc Natl Acad Sci USA 1992;89:7871-5.
20. Aichele P, Hengartner H, Zinkernagel RM, Schulz M. Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J Exp Med 1990;171:1815-20.
21. Kast WM, Roux L, Curren J et al. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc Natl Acad Sci USA 1991;88:2283-7.
22. School B, Zugel U, Ruppert T, Kaufmann SH. Elongated peptides, not the predicted nonapeptide stimulate a major histocompatibility complex class I-restricted cytotoxic T lymphocyte clone with specificity for a bacterial heat shock protein. Eur J Immunol 1994;24:3161-9.
23. Tascon RE, Colston MJ, Ragno S, Stavropoulos E, Gregory D, Lowrie DB. Vaccination against tuberculosis by DNA injection. Nature Medicine 1996;2:888-92.
24. Frumento G, Harris PE, Gawinowicz MA, Suciu FN, Pernis B. Sequence of a prominent 16-residue self-peptide bound to HLA-B27 in a lymphoblastoid cell line. Cell Immunol 1993;152:623-6.
25. Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, Eisenbach L. CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 1994;369: 67-71.
26. Dahl M, Beverley PCL, Stauss HJ. Synthetic peptide derived from the tumor-associated protein mdm2 can stimulate autoreactive, high avidity cytotoxic T lymphocytes that recognise naturally processed protein. J Immunol 1996;157:239-46.
27. Cooper AM, Dalton DK, Stcwart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993;178:2243-7.
28. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-54.
29. Takahashi H, Takeshita T, Morein B, Putney S, Germain RN, Berzofsky JA. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature 1990;344: 873-5.
30. Reddy R, Zhou F, Nair S, Huang L, Rouse BT. In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. J Immunol 1992;148:1585-9.
31. Deres K, Schild H, Wiesmuller K-H, Jung G, Rammensee H-G. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 1989;342:561.
32. De Bruijn M, Jackson MR, Peterson PA. Phagocyte-induced antigen-specific activation of unprimed CD8+ T cells in vitro. Eur J Immunol 1995;25:1274-85.
33. Ciernik IF, Berzofsky JA, Carbone DP. Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes. J Immunol 1996;156:2369-75.
34. Takahashi H, Nakagawa Y, Yokomuro K, Bcrzofsky JA. Induction of CD8+ cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells, Int Immunol 1993;5:849-57.
35. De Bruijn M, Schumacher TN, Nieland JD, Ploegh HL, Kast WM, Melief CJ. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses. Eur J Immunol 1991;21:2963-70.
36. Udono H, Srivastava PK. Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 1993;178:1391-6.
37. Harty JT, Bevan MJ. CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J Exp Med 1992;175:1531-8.
38. Pope M, Kotlarski I. Detection of Salmonella-specific L3T4+ and Lyt-2+ T cells which can proliferate in vitro and mediate delayed-type hypersensitivity reactivity. Immunology 1994;81:183-91.
39. Pope M, Kotlarski I, Doherty K. Induction of Lyt-2+ cytotoxic T lymphocytes following primary and secondary Salmonella infection. Immunology 1994;81:177-82.
40. Vordermeier HM. T cell recognition of mycobacterial antigens. In: eds. Saltini C, Ivanyi J, Advances in Research and Control of Tuberculosis. Eur Resp J 1995;8 (Supp. 20):657s-67s.
41. Shirai M, Pendleton CD, Berzofsky JA. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. J Immunol 1992;148: 1657-67.
42. Sidney J, Grey HM. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum Immunol 1996;45:79-93.
43. Sidney J, Grey HM, Kubo RT, Sette A. Practical, biochemical and evolutionary implications of the discovery of HLA class 1 supermotifs. Immunology Today 1996;17:261-6.